Does SECUKINUMAB Cause Forced expiratory volume decreased? 6 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Forced expiratory volume decreased have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
6
Reports of Forced expiratory volume decreased with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Forced expiratory volume decreased From SECUKINUMAB?
Of the 6 reports, 6 (100.0%) required hospitalization.
Is Forced expiratory volume decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Forced expiratory volume decreased?
OMALIZUMAB (1,497)
ALBUTEROL (344)
PREDNISONE (335)
MONTELUKAST (274)
TIOTROPIUM (236)
MEPOLIZUMAB (209)
METFORMIN (183)
BUDESONIDE\FORMOTEROL (171)
BUDESONIDE (150)
LEVOFLOXACIN (138)
Which SECUKINUMAB Alternatives Have Lower Forced expiratory volume decreased Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG